155 related articles for article (PubMed ID: 1767770)
1. [The diagnostic value of flow cytometric DNA analysis in bladder cancer--comparison with conventional cytology].
Kawasaki T
Hinyokika Kiyo; 1991 Nov; 37(11):1481-9. PubMed ID: 1767770
[TBL] [Abstract][Full Text] [Related]
2. The relative value of cytometry and cytology in the management of bladder cancer: the Memorial Sloan-Kettering Cancer Center experience.
Badalament RA; Fair WR; Whitmore WF; Melamed MR
Semin Urol; 1988 Feb; 6(1):22-30. PubMed ID: 3291043
[TBL] [Abstract][Full Text] [Related]
3. The role of urinary cytology for detection of bladder cancer.
Planz B; Jochims E; Deix T; Caspers HP; Jakse G; Boecking A
Eur J Surg Oncol; 2005 Apr; 31(3):304-8. PubMed ID: 15780568
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
5. [Use of flow cytometry in the diagnosis of bladder tumor].
Ling CH
Zhonghua Wai Ke Za Zhi; 1989 May; 27(5):286-8, 317. PubMed ID: 2806005
[TBL] [Abstract][Full Text] [Related]
6. [Flow cytofluorometric DNA analysis in fresh bladder specimens and its correlations between cytology and mitotic index].
Song LF
Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):289-91, 318. PubMed ID: 2086099
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry of transitional cell carcinoma of the urinary bladder: influence of prior local therapy.
Têtu B; Katz RL; Kalter SP; Von Eschenbach AC; Barlogie B
Semin Diagn Pathol; 1987 Aug; 4(3):243-50. PubMed ID: 3671911
[TBL] [Abstract][Full Text] [Related]
8. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
[TBL] [Abstract][Full Text] [Related]
9. DNA breaks as measured by the alkaline comet assay in exfoliated cells as compared to voided urine cytology in the diagnosis of bladder cancer: a study of 105 subjects.
Fracasso ME; Franceschetti P; Doria D; Talamini G; Bonetti F
Mutat Res; 2004 Nov; 564(1):57-64. PubMed ID: 15474411
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors.
Grégoire M; Fradet Y; Meyer F; Têtu B; Bois R; Bédard G; Charrois R; Naud A
J Urol; 1997 May; 157(5):1660-4. PubMed ID: 9112500
[TBL] [Abstract][Full Text] [Related]
11. Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive?
Raitanen MP; Aine RA; Kaasinen ES; Liukkonen TJ; Kylmälä TM; Huhtala H; Tammela TL;
Scand J Urol Nephrol; 2002; 36(3):213-7. PubMed ID: 12201938
[TBL] [Abstract][Full Text] [Related]
12. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
13. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
14. Detection of bladder carcinoma in females by flow cytometry and cytology.
Hermansen DK; Badalament RA; Fair WR; Kimmel M; Whitmore WF; Melamed MR
Cytometry; 1989 Nov; 10(6):739-42. PubMed ID: 2582965
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
[TBL] [Abstract][Full Text] [Related]
16. [A comparative study of the sensitivity of bladder washing flow cytometry, voided urine cytology and bladder washing cytology in the detection of bladder carcinoma].
Tachibana M; Jitsukawa S; Tazaki H; Tashiro Y
Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1025-30. PubMed ID: 2607716
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases.
Bakhos R; Shankey TV; Flanigan RC; Fisher S; Wojcik EM
Diagn Cytopathol; 2000 Feb; 22(2):65-9. PubMed ID: 10649514
[TBL] [Abstract][Full Text] [Related]
18. The role of cytology in the diagnosis, detection and follow-up of bladder cancer.
Koss LG; Esposti L; Nagayama T; De Voogt H; Farsund T; Felderhof J; Friedell G; Reiss E; Tanke H; Tribukait B
Prog Clin Biol Res; 1986; 221():97-108. PubMed ID: 3809190
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Bard BTA test with voided urine and bladder wash cytology in the diagnosis and management of cancer of the bladder.
Leyh H; Hall R; Mazeman E; Blumenstein BA
Urology; 1997 Jul; 50(1):49-53. PubMed ID: 9218018
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometry based on heterogeneity index score compared with urine cytology to evaluate their diagnostic efficacy in bladder tumor.
Jitsukawa S; Tachibana M; Nakazono M; Tazaki H; Addonizio JC
Urology; 1987 Feb; 29(2):218-22. PubMed ID: 3811103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
